Cargando…
Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study
BACKGROUND: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217033/ https://www.ncbi.nlm.nih.gov/pubmed/32511426 http://dx.doi.org/10.1101/2020.03.06.20032417 |
_version_ | 1783532534382985216 |
---|---|
author | Qin, Jing You, Chong Lin, Qiushi Hu, Taojun Yu, Shicheng Zhou, Xiao-Hua |
author_facet | Qin, Jing You, Chong Lin, Qiushi Hu, Taojun Yu, Shicheng Zhou, Xiao-Hua |
author_sort | Qin, Jing |
collection | PubMed |
description | BACKGROUND: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in recent published studies, but all have their own limitations. In this study, we propose a novel low-cost and accurate method to estimate the incubation distribution. METHODS: We have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from Wuhan and then following them until their symptoms developed. The renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. Under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. Such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data. FINDINGS: The estimated distribution of forward time fits the observations in the collected data well. The estimated median of incubation period is 8·13 days (95% confidence interval [CI]: 7·37–8·91), the mean is 8·62 days (95% CI: 8·02–9·28), the 90th percentile is 14·65 days (95% CI: 14·00–15·26), and the 99th percentile is 20·59 days (95% CI: 19·47, 21·62). Compared with results in other studies, the incubation period estimated in this study is longer. INTERPRETATION: Based on the estimated incubation distribution in this study, about 10% of patients with COVID-19 would not develop symptoms until 14 days after infection. Further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods. |
format | Online Article Text |
id | pubmed-7217033 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-72170332020-06-07 Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study Qin, Jing You, Chong Lin, Qiushi Hu, Taojun Yu, Shicheng Zhou, Xiao-Hua medRxiv Article BACKGROUND: The current outbreak of coronavirus disease 2019 (COVID-19) has quickly spread across countries and become a global crisis. However, one of the most important clinical characteristics in epidemiology, the distribution of the incubation period, remains unclear. Different estimates of the incubation period of COVID-19 were reported in recent published studies, but all have their own limitations. In this study, we propose a novel low-cost and accurate method to estimate the incubation distribution. METHODS: We have conducted a cross-sectional and forward follow-up study by identifying those asymptomatic individuals at their time of departure from Wuhan and then following them until their symptoms developed. The renewal process is hence adopted by considering the incubation period as a renewal and the duration between departure and symptom onset as a forward recurrence time. Under mild assumptions, the observations of selected forward times can be used to consistently estimate the parameters in the distribution of the incubation period. Such a method enhances the accuracy of estimation by reducing recall bias and utilizing the abundant and readily available forward time data. FINDINGS: The estimated distribution of forward time fits the observations in the collected data well. The estimated median of incubation period is 8·13 days (95% confidence interval [CI]: 7·37–8·91), the mean is 8·62 days (95% CI: 8·02–9·28), the 90th percentile is 14·65 days (95% CI: 14·00–15·26), and the 99th percentile is 20·59 days (95% CI: 19·47, 21·62). Compared with results in other studies, the incubation period estimated in this study is longer. INTERPRETATION: Based on the estimated incubation distribution in this study, about 10% of patients with COVID-19 would not develop symptoms until 14 days after infection. Further study of the incubation distribution is warranted to directly estimate the proportion with long incubation periods. Cold Spring Harbor Laboratory 2020-03-10 /pmc/articles/PMC7217033/ /pubmed/32511426 http://dx.doi.org/10.1101/2020.03.06.20032417 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/It is made available under a CC-BY-NC-ND 4.0 International license (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Article Qin, Jing You, Chong Lin, Qiushi Hu, Taojun Yu, Shicheng Zhou, Xiao-Hua Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
title | Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
title_full | Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
title_fullStr | Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
title_full_unstemmed | Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
title_short | Estimation of incubation period distribution of COVID-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
title_sort | estimation of incubation period distribution of covid-19 using disease onset forward time: a novel cross-sectional and forward follow-up study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217033/ https://www.ncbi.nlm.nih.gov/pubmed/32511426 http://dx.doi.org/10.1101/2020.03.06.20032417 |
work_keys_str_mv | AT qinjing estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy AT youchong estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy AT linqiushi estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy AT hutaojun estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy AT yushicheng estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy AT zhouxiaohua estimationofincubationperioddistributionofcovid19usingdiseaseonsetforwardtimeanovelcrosssectionalandforwardfollowupstudy |